RT Journal Article
SR Electronic
T1 <em>Tcte1</em> knockout influence on energy chain transportation, apoptosis and spermatogenesis – implications for male infertility
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.17.22282339
DO 10.1101/2022.11.17.22282339
A1 Marta Olszewska
A1 Agnieszka Malcher
A1 Tomasz Stokowy
A1 Nijole Pollock
A1 Andrea J. Berman
A1 Sylwia Budkiewicz
A1 Marzena Kamieniczna
A1 Hanna Jackowiak
A1 Piotr Jedrzejczak
A1 Alexander N. Yatsenko
A1 Maciej Kurpisz
YR 2022
UL http://medrxiv.org/content/early/2022/11/25/2022.11.17.22282339.abstract
AB STUDY QUESTION Is Tcte1 mutation causative for male infertility?SUMMARY ANSWER Collected data underline the complex and devastating effect of the single-gene mutation on testicular molecular network, leading to male reproductive failure.WHAT IS KNOWN ALREADY Latest data revealed mutations in genes related to axonemal dynein arms as causative for morphology and motility abnormalities in spermatozoa of infertile males, including dysplasia of fibrous sheath (DFS) and multiple morphological abnormalities in the sperm flagella (MMAF). The nexin-dynein regulatory complex (N-DRC) coordinates the dynein arm activity, and is built from DRC1-DRC7 proteins. DRC5 (TCTE1) – one of N-DRC element, has been already reported as a candidate for abnormal sperm flagella beating, however, only in restricted manner with no clear explanation of respective observations.STUDY DESIGN, SIZE, DURATION Using CRISPR/Cas9 genome editing technique, mouse knockout line of Tcte1 gene was created on the basis of C57Bl/6J strain. Then, the mouse reproductive potential, semen characteristics, testicular gene expression level, sperm ATP and testis apoptosis level measurements have been performed, followed by visualization of N-DRC proteins in sperm, and protein modeling in silico. Also, a pilot genomic sequencing study of samples from human infertile males (n=248) was applied for screening of TCTE1 variants.PARTICIPANTS/MATERIALS, SETTING, METHODS To check the reproductive potential of KO mice, adult animals were crossed for delivery of three litters per caged pair, but no longer than for 6 months, in various combinations of zygosity. All experiments were performed for wild type (WT – control group), heterozygous Tcte1+/−, and homozygous Tcte1−/− male mice. Gross anatomy was performed on testis and epididymis, followed by semen analysis. Sequencing of RNA (RNAseq; Illumina) has been done for mice testis tissues. STRING interactions have been checked for protein-protein interactions, based on changed expression level of corresponding genes identified in the mouse testis RNAseq experiments. Immunofluorescence in situ staining was performed to detect the N-DRC complex proteins: Tcte1 (Drc5), Drc7, Fbxl13 (Drc6), and Eps8l1 (Drc3) in mouse spermatozoa. To determine the ATP amount in spermatozoa, the luminescence level was measured. Also, immunofluorescent in situ staining was performed to check the level of apoptosis via caspase 3 visualization on mouse testis samples. DNA from whole blood samples of infertile males (n=137 non-obstructive azoospermia or cryptozoospermia, n=111 samples with spectrum of oligoasthenoteratozoospermia, including n=47 with asthenozoospermia) has been extracted to perform genomic sequencing (WGS, WES or Sanger). Protein prediction modeling of human identified variants and the exon 3 structure deleted in mouse knockout has been also performed.MAIN RESULTS AND THE ROLE OF CHANCE No progeny at all was found for homozygous males with revealed oligoasthenoteratozoospermia, while heterozygous animals (fertile) manifested oligozoospermia, suggesting haploinsufficiency. RNA-sequencing of the testicular tissue showed the influence of Tcte1 mutations on the expression pattern of 21 genes responsible for mitochondrial ATP processing, linked with apoptosis, or spermatogenesis. In Tcte1−/− males the protein revealed only residual amounts in sperm head nucleus, and was not transported to sperm flagella, as other N-DRC components. Decreased ATP level (2.4-fold lower) was found in spermatozoa of homozygous mice, together with disturbed tail:midpiece ratio, leading to abnormal sperm tail beating. Casp3-positive signals (indicating apoptosis) were observed in spermatogonia only, at similar level in all three mouse genotypes. Mutation screening of human infertile males revealed 1 novel and 5 ultrarare heterogeneous variants (predicted as disease causing) in 6.05% of patients studied. Protein prediction modeling of identified variants revealed changes in the protein surface charge potential, leading to disruption in helix flexibility or its dynamics, thus, suggesting the disrupted TCTE1 interaction with its binding partners located within the axoneme.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Science Centre in Poland, grants no.: 2015/17/B/NZ2/01157 and 2020/37/B/NZ5/00549 (to MK), 2017/26/D/NZ5/00789 (to AM), and HD096723, GM127569-03, NIH SAP #4100085736 PA DoH (to AY).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Local Ethical Committee for Animal Experiments at the Poznan University of Life Sciences gave approvals no. 1/2014 and 18/2017. Ministry of Environment gave approval no. 70/2017. Local Bioethics Committee of Poznan University of Medical Sciences gave approval no. 1003/18. National Bioethical Committee, Ministry of Health, Warsaw, Poland gave the approval no. OKB-5-2/15.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this published article and its supplemental information files. Supplementary files are deposited in Zenodo at https://doi.org/10.5281/zenodo.7330637 RNAseq data are available in GEO database (https://www.ncbi.nlm.nih.gov/geo/) under the accession number: GSE207805. The results described in the publication are based on whole-genome or exome sequencing data which includes sensitive information in the form of patient specific germline variants. Information regarding such variants must not be shared publicly following the European Union legislation described in the following document: https://publications.jrc.ec.europa.eu/repository/bitstream/JRC113479/policy_report_-_review_of_eu_national_legislation_on_genomics_-_with_identifiers_1.pdf, therefore the access to raw data that support findings of this study are available from the corresponding author upon reasonable request. https://doi.org/10.5281/zenodo.7330637